STOCK TITAN
  1. Home
  2. Sec-filings
  3. AIP
  4. [Form 4] Arteris, Inc. Insider Trading Activity

Arteris, Inc. (NASDAQ: AIP) director trades 70,000 shares in 10b5-1 plan

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Arteris, Inc. director Saiyed Atiq Raza, through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, sold a total of 70,000 common shares on August 3, 2026 in three open-market transactions at weighted average prices of $28.7765, $29.9898 and $30.3009 per share within stated price ranges. The sales were made pursuant to a Rule 10b5-1 trading plan adopted on November 7, 2025. A separate holding entry reports 4,703 common shares held directly.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider RAZA SAIYED ATIQ
Role Director
Sold 70,000 shs ($2.10M)
Type Security Shares Price Value
Sale Common Stock F1, F2, F3 5,921 $28.7765 $170K
Sale Common Stock F1, F4 36,827 $29.9898 $1.10M
Sale Common Stock F1, F5 27,252 $30.3009 $826K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 0 shares (Indirect, By Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012); Common Stock — 4,703 shares (Direct)
Footnotes (5)
  1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.
  2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.11 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
  4. F4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.17 to $30.16 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.17 to $30.61 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Total shares sold 70,000 shares Aggregate Arteris common stock sold on August 3, 2026 by the revocable trust
First block weighted average price $28.7765 per share 5,921-share sale; individual trades ranged from $28.17 to $29.11
Second block weighted average price $29.9898 per share 36,827-share sale; individual trades ranged from $29.17 to $30.16
Third block weighted average price $30.3009 per share 27,252-share sale; individual trades ranged from $30.17 to $30.61
Direct shares held 4,703 shares Common stock reported as directly held by the reporting person as of August 3, 2026
10b5-1 plan adoption date November 7, 2025 Date the trading plan governing these sales was adopted
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan that was adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
revocable trust financial
"Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
indirect ownership financial
"The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider stock sale did Arteris (AIP) report for Saiyed Atiq Raza?

Arteris reported that director Saiyed Atiq Raza, via a revocable trust, sold a total of 70,000 shares of Arteris common stock on August 3, 2026. The transactions were executed in three open-market blocks at different weighted average prices.

How many Arteris (AIP) shares were sold in each block and at what prices?

The revocable trust sold 5,921 shares at $28.7765, 36,827 shares at $29.9898, and 27,252 shares at $30.3009 per share. Each price represents a weighted average for multiple trades executed within disclosed intraday price ranges.

Were the Arteris (AIP) insider sales made under a Rule 10b5-1 trading plan?

Yes. A footnote states the transactions were made pursuant to a 10b5-1 trading plan adopted by the reporting person on November 7, 2025. Such pre-arranged plans can reduce the informational value of short-term trading timing.

Who actually held the Arteris (AIP) shares sold in this filing?

The sold shares were held by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which Raza serves as trustee. The Form 4 describes the transactions as indirect ownership through this trust, rather than directly owned shares.

How many Arteris (AIP) shares does Saiyed Atiq Raza hold directly after these transactions?

The filing reports a separate holding entry of 4,703 Arteris common shares held directly by the reporting person as of August 3, 2026. The document does not specify the trust’s remaining share balance after the reported sales.

SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RAZA SAIYED ATIQ
(Last)(First)(Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300
(Street)
CAMPBELL CALIFORNIA 95008
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/03/2026S(1)5,921D$28.7765(2)64,079IBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012(3)
Common Stock08/03/2026S(1)36,827D$29.9898(4)27,252IBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012
Common Stock08/03/2026S(1)27,252D$30.3009(5)0.00IBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012
Common Stock4,703D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.
2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.11 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.17 to $30.16 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.17 to $30.61 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for S. Atiq Raza08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR